Since literature exists showing that hyperglycemia, the advanced glycation end-products (AGEs)/advanced glycation end-product receptor (RAGE) axis, oxidative stress, and immune activation are integral interconnected pathological features in diabetes including GDM [67,68], further research in this field should be carried out in the patients enrolled here. The gene discussed is AGER; the disease is Hyperglycemia.